P
P-Cure
P-Cure is a biotech company has developed a patient centric proton therapy solution with clinical benefits and financial advantages
About P-Cure
P-Cure is a pioneering company in the field of proton therapy, focusing on advanced cancer treatment solutions. The company serves healthcare providers, particularly radiation oncology departments, by offering a cost-effective and space-efficient alternative to traditional proton therapy systems. Operating in the medical technology market, P-Cure's business model revolves around the development and sale of its proprietary proton therapy systems, which are designed to be significantly smaller and require less shielding than conventional systems. This enables healthcare facilities to adopt cutting-edge cancer treatment technology with lower initial investment and operational costs.
Read full description
P-Cure's revenue is generated through the sale of its proton therapy systems, as well as ongoing maintenance and support services. The company's core product integrates FDA-cleared, in-room diagnostic quality 4D CT imaging with adaptive therapy workflows and pencil beam scanning technology. This combination ensures that treatment plans are continuously updated and delivered with high precision, minimizing radiation exposure to healthy tissues and organs.
The company's innovative approach has been endorsed by industry opinion leaders and is expected to significantly improve clinical outcomes for cancer patients. By imaging patients in the upright position, P-Cure's technology allows for more accurate targeting of tumors, particularly in lung cancer cases, thereby enhancing treatment efficacy.
At a glance
- Status
- Operational
- Founded
- 2007
- Headquarters
- Shilat, Israel
- Employees
- 44
- Open positions
- None listed
- Dealroom signal
- 41.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, X-Ray, Radiation
- Technology
- Artificial Intelligence, 3D Technology, Big Data, Deep Tech, Computer Vision
- Business model
- Manufacturing
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jul 2019 | $15M | $60M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for P-Cure is 790 monthly website visits, down 47.3% over the last three months. P-Cure's team declined 4.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about P-Cure on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See P-Cure’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.